Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€0.036

€0.036

-64.730%
-
-64.730%
-
 
07.11.23 / Tradegate WKN: 540888 / Name: Leoni / Stock / Machinery, Equipment & Components / Small Cap / We currently do not receive price updates for this security
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
The full analysis of the stock Leoni AG is only available for our menbers.
Not a member yet? Sign up for free!

Financial data and news for Leoni

sharewise wants to provide you with the best news and tools for Leoni, so we directly link to the best financial data sources.

News

Kura Oncology Reports 50% Response Rate in RCC Combination StudyPhoto, wide shot, wide-angle lens,  Aerospace components, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://img.midjourneyapi.xyz/temp/3938f51e-9b01-45a9-aed1-ff9d047063fc.png
Kura Oncology Reports 50% Response Rate in RCC Combination Study

Key Points

Kura Oncology Q1 Earnings Call HighlightsPhoto, wide shot, wide-angle lens,  Metal fabrication, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Hiroshi Sugimoto: https://img.midjourneyapi.xyz/temp/568784d0-c41a-4663-ab01-91f29a370903.png
Kura Oncology Q1 Earnings Call Highlights

Kura Oncology (NASDAQ:KURA) reported $5.8 million in first-quarter net product revenue from KOMZIFTI, its first commercial product, and said the launch is